Pharmacological applications of inorganic complexes

被引:64
作者
Bakhtiar, R
Ochiai, EI
机构
[1] Stevens Inst Technol, Dept Chem & Chem Biol, Hoboken, NJ 07030 USA
[2] Juniata Coll, Dept Chem, Huntingdon, PA 16652 USA
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1999年 / 32卷 / 05期
关键词
metal complexes; bioinorganic chemistry; pharmacology; metabolism; bio-organometallic chemistry;
D O I
10.1016/S0306-3623(98)00223-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inorganic complexes have long been utilized for many therapeutic purposes. They were used or tried, perhaps because of the general notion that inorganic compounds (e.g., metal complexes) are toxic and a controlled use of such a compound may suppress some biological process. In this review, we briefly outline the properties of several selected groups of inorganic complexes and how they can affect biological systems and contribute to human pathologies. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:525 / 540
页数:16
相关论文
共 94 条
[81]   Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy [J].
Sjoberg, S ;
Carlsson, J ;
Ghaneolhosseini, H ;
Gedda, L ;
Hartman, T ;
Malmquist, J ;
Naeslund, C ;
Olsson, P ;
Tjarks, W .
JOURNAL OF NEURO-ONCOLOGY, 1997, 33 (1-2) :41-52
[82]   The chemistry of neutron capture therapy [J].
Soloway, AH ;
Tjarks, W ;
Barnum, BA ;
Rong, FG ;
Barth, RF ;
Codogni, IM ;
Wilson, JG .
CHEMICAL REVIEWS, 1998, 98 (04) :1515-1562
[83]   NEWER AND OLDER ANTIDEPRESSANTS - A COMPARATIVE REVIEW OF DRUG-INTERACTIONS [J].
SPINA, E ;
PERUCCA, E .
CNS DRUGS, 1994, 2 (06) :479-497
[84]  
Stubbe J, 1996, ACCOUNTS CHEM RES, V29, P322, DOI 10.1021/ar9501333
[85]  
Thorp HH, 1995, ADV CHEM SERIES, V246
[86]   New promising anticancer agents in development: What comes next? [J].
Verweij, J .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 :S3-S10
[87]  
WEHRLI F, 1988, BIOL MAGNETIC RESONA
[88]   NEW CISPLATIN ANALOGS IN DEVELOPMENT - A REVIEW [J].
WEISS, RB ;
CHRISTIAN, MC .
DRUGS, 1993, 46 (03) :360-377
[89]  
Woo ES, 1997, CANCER RES, V57, P4236
[90]   NMR DETERMINATION OF THE STRUCTURES OF PEROXYCOBALT(III) BLEOMYCIN AND COBALT(III) BLEOMYCIN, PRODUCTS OF THE AEROBIC OXIDATION OF COBALT(II) BLEOMYCIN BY DIOXYGEN [J].
XU, RX ;
NETTESHEIM, D ;
OTVOS, JD ;
PETERING, DH .
BIOCHEMISTRY, 1994, 33 (04) :907-916